People with Parkinson’s disease experience a degenerative decline in levels of dopamine over time. Deep brain stimulation (DBS) can help reduce related symptoms, including tremor. See how DBS technology is bringing faster relief to patients who need it. bit.ly/49ZyABr

Our work in health care comes with a responsibility to create positive change in the world around us. To learn more about our progress, read key takeaways from our 2023 Performance Report: bit.ly/3w43fzJ

How does a company ensure their corporate responsibility efforts are moving in the right direction? It starts with a focus on company values, says Kathryn Unger, VP, environmental, social and governance. linkedin.com/pulse/real-pro…

Here are a few highlights from our first quarter earnings announcement: news.bostonscientific.com/interested-in-…

Happening now: Q1 2024 earnings conference call & webcast. Tune in here: bit.ly/3Ju137H $BSX

Boston Scientific announces results for Q1 2024: bit.ly/3WcLn08 $BSX

Tomorrow morning we’ll host a conference call & webcast to discuss Q1 2024 financial results. Tune in here: bit.ly/44bjuau $BSX

As part of our mission to advance science for life, we’re committed to innovating new products, empowering people, and protecting the planet we all share. Learn more about our impact in our 2023 Performance Report: bit.ly/3vTGQoI

“This is one of the most transformative technologies I’ve seen in my time as a physician.” Read in The Wall Street Journal why the FARAPULSE™ Pulsed Field Ablation System may shift the future of #AFib treatment: partners.wsj.com/boston-scienti…

Women and people of color are severely underrepresented in clinical trial research. Learn how our Close the Gap team is committed to improving these numbers through clinical trial diversity. #MinorityHealthMonth bit.ly/4aB3wZI

Watch Matt McDonald, director of R&D, Neuromodulation, speak at #WIREDHealth about delivering innovative chronic pain treatment to patients worldwide. WIRED UK Events WIRED youtube.com/watch?v=OgH8HG…

Our innovative products, processes and culture have earned us recognition as a 2024 Most Innovative Company by FORTUNE 🏆

Endoluminal surgery (ELS) is being hailed as the next generation of surgery. Dr. Brian Dunkin and Mike Jones discuss how the ELS products from our Apollo Endosurgery acquisition represent a step forward in GI care, including for treatment of obesity: bit.ly/3wXg7Ye

Matt McDonald, director of R&D, Neuromodulation, speaks at #WIREDHealth about transforming the future of chronic pain care. WIRED UK Events WIRED

Chairman and CEO Mike Mahoney and SVP, Investor Relations Jon Monson spoke about company growth fueled by recent product innovations at #TDCowenHealthCare . Listen to the full fireside chat here: bit.ly/48KqSdO

As Relievant Medsystems has officially become part of Boston Scientific, Jim Cassidy, president, Neuromodulation, shares his thoughts on how the acquisition stands to benefit patients living with chronic pain. bit.ly/3TwVqeO

Join us in celebrating women’s achievements and advocating for a more equitable future this International Women's Day. #InspireInclusion #IWD24

Don't miss Boston Scientific at #WIREDHealth on March 19 at Kings Place, London.

Get tickets at health.wired.com

This #WorldObesityDay , Boston Scientific stands united with World Obesity Day to address the complex causes of obesity. It’s on all of us.

Now FDA-approved, this technology will help advance treatment options for patients with coronary artery disease.